Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios-Athanasios Dimopoulos

Showing results (221-230 of 283) with videos related to

Pageof 29
Sort By:
Frontiers in Immunology|June 13, 2022
Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological MalignanciesCristina Bergamaschi, Maria Pagoni, Margherita Rosati, et al.
Plos One|June 4, 2016
The Development of an Angiogenic Protein "Signature" in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic ProfilingSofia-Paraskevi Trachana, Eleftherios Pilalis, Nikos G Gavalas, et al.
British Journal of Cancer|October 31, 2021
miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcomeMaria-Alexandra Papadimitriou, Aristea-Maria Papanota, Panagiotis G Adamopoulos, et al.
British Journal of Haematology|July 13, 2026
Characteristics and clinical course of younger patients with asymptomatic monoclonal gammopathiesEirini Solia, Foteini Theodorakakou, Panagiotis Malandrakis, et al.
Biomedicines|December 24, 2021
tRNA Derivatives in Multiple Myeloma: Investigation of the Potential Value of a tRNA-Derived Molecular SignatureParaskevi Karousi, Aristea-Maria Papanota, Pinelopi I Artemaki, et al.
Cancers|November 14, 2019
Antitumor Reactive T-Cell Responses Are Enhanced In Vivo by DAMP Prothymosin Alpha and Its C-Terminal DecapeptideAnastasios I Birmpilis, Chrysoula-Evangelia Karachaliou, Pinelopi Samara, et al.
British Journal of Haematology|January 22, 2026
Clinical outcomes in newly diagnosed patients with Waldenström's macroglobulinaemia treated in a tertiary academic centreMaria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, et al.
Hemasphere|October 26, 2022
Mineralocorticoid Receptor Pathway Is a Key Mediator of Carfilzomib-induced Nephrotoxicity: Preventive Role of EplerenonePanagiotis Efentakis, Sofia Lamprou, Manousos Makridakis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's MacroglobulinemiaMeletios Athanasios Dimopoulos, Morie A Gertz, Efstathios Kastritis, et al.
Cancers|November 7, 2020
Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple MyelomaKonstantinos Papadimitriou, Nikolaos Tsakirakis, Panagiotis Malandrakis, et al.
Pageof 29

Showing results (221-230 of 283) with videos related to

Sort By:
Pageof 29
Frontiers in Immunology|June 13, 2022
Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological MalignanciesCristina Bergamaschi, Maria Pagoni, Margherita Rosati, et al.
Plos One|June 4, 2016
The Development of an Angiogenic Protein "Signature" in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic ProfilingSofia-Paraskevi Trachana, Eleftherios Pilalis, Nikos G Gavalas, et al.
British Journal of Cancer|October 31, 2021
miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcomeMaria-Alexandra Papadimitriou, Aristea-Maria Papanota, Panagiotis G Adamopoulos, et al.
British Journal of Haematology|July 13, 2026
Characteristics and clinical course of younger patients with asymptomatic monoclonal gammopathiesEirini Solia, Foteini Theodorakakou, Panagiotis Malandrakis, et al.
Biomedicines|December 24, 2021
tRNA Derivatives in Multiple Myeloma: Investigation of the Potential Value of a tRNA-Derived Molecular SignatureParaskevi Karousi, Aristea-Maria Papanota, Pinelopi I Artemaki, et al.
Cancers|November 14, 2019
Antitumor Reactive T-Cell Responses Are Enhanced In Vivo by DAMP Prothymosin Alpha and Its C-Terminal DecapeptideAnastasios I Birmpilis, Chrysoula-Evangelia Karachaliou, Pinelopi Samara, et al.
British Journal of Haematology|January 22, 2026
Clinical outcomes in newly diagnosed patients with Waldenström's macroglobulinaemia treated in a tertiary academic centreMaria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, et al.
Hemasphere|October 26, 2022
Mineralocorticoid Receptor Pathway Is a Key Mediator of Carfilzomib-induced Nephrotoxicity: Preventive Role of EplerenonePanagiotis Efentakis, Sofia Lamprou, Manousos Makridakis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's MacroglobulinemiaMeletios Athanasios Dimopoulos, Morie A Gertz, Efstathios Kastritis, et al.
Cancers|November 7, 2020
Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple MyelomaKonstantinos Papadimitriou, Nikolaos Tsakirakis, Panagiotis Malandrakis, et al.
Pageof 29